News
New dean of Basic Sciences aims to take Vanderbilt to the next level in biomedical research, drug discovery
Apr. 3, 2023—Whether working on dynamic discoveries in the lab, connecting with students and faculty, or pursuing his passion for nature photography, acclaimed biomedical researcher John Kuriyan is inspired by his recent move to join Vanderbilt as the new dean of the School of Medicine Basic Sciences and Distinguished University Professor.
E. coli uses serine to abide acidity
Mar. 23, 2023—E. coli bacteria are the main cause of urinary tract infections. It is thought that we acquire many of the E. coli strains through ingestion, which means that these bacteria must survive the harsh conditions in the stomach, which is acidic enough to dissolve skin. How do these bacteria survive acidic conditions that should destroy...
Goldenring’s gastrointestinal research contributions lauded
Mar. 23, 2023—James Goldenring, MD, PhD, the Paul W. Sanger Professor of Experimental Surgery at Vanderbilt University Medical Center, has been honored by the American Gastroenterological Association for making significant contributions to understanding gastrointestinal disease. Goldenring, vice chair of Surgical Research for the Section of Surgical Sciences and professor of Surgery and of Cell and Developmental Biology,...
Sanders promoted to Vice Dean of Basic Sciences
Mar. 8, 2023—By Leah Mann Chuck Sanders, Aileen M. Lange and Annie Mary Lyle Chair of Cardiovascular Research and professor of biochemistry and medicine, has recently been promoted from associate dean for research to vice dean of the Vanderbilt School of Medicine Basic Sciences. Sanders received his Ph.D. in chemistry/biochemistry at Ohio State University under the mentorship...
Pham & McLean elected 2022 AAAS fellows
Feb. 1, 2023—Five Vanderbilt University and Vanderbilt University Medical Center faculty members were elected as 2022 fellows of the American Association for the Advancement of Science. They were selected by a group of their AAAS peers.
Vanderbilt biochemists join international researchers in discovery of the first new antibiotic for urinary tract infections in more than 20 years
Jan. 18, 2023—Neil Osheroff, John Coniglio Chair in Biochemistry and professor of biochemistry and medicine, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections in more than 20 years. “We now have a direct path connecting the work conducted in our...
Renã Robinson receives National Institutes of Health grant for faculty success program to promote equity in science
Jan. 18, 2023—Renã Robinson, Dorothy Wingfield Phillips Chancellor’s Faculty Fellow and professor of chemistry, received $2.04 million in funding from the National Institutes of Health to start a program that will help underrepresented minority faculty further their success in STEM. Collaborators on the grant include researchers from the University of Kentucky and the University of North Carolina....
New screening method could pave the way for future cancer drug discoveries
Jan. 18, 2023—The laboratories of Brian Bachmann, professor of chemistry, biochemistry and pharmacology, and Jonathan Irish, associate professor of cell and developmental biology and pathology, microbiology and immunology, have developed a method to discover new small molecules that may kill cancer cells by working through the body’s immune system. The method is the first of its kind,...
McLean & Friedman named to associate provost role
Dec. 16, 2022—Two veteran faculty members, highly regarded for their administrative leadership within their respective departments and their deep commitment to research and student development, have been appointed associate provosts at Vanderbilt University, announced Provost and Vice Chancellor for Academic Affairs C. Cybele Raver. John McLean, Stevenson Professor of Chemistry and chair of the Department of Chemistry,...
James Crowe awarded “TIME” Best Inventions of 2022
Dec. 5, 2022—Dr. James Crowe Jr., director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center, led the team that discovered a monoclonal antibody combination that protects against COVID-19. Optimized and developed by AstraZeneca, the monoclonal antibody combination called Evusheld is the first treatment to protect adults and children 12 years and older who have compromised immune...